Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Income Tax Expense Over TimeContracting
Percentile Rank27
Studio
Year-over-Year Change

Income taxes paid or accrued

Percentile
P27
Within normal range
vs 3Y Ago
-0.4x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$-1.22M+26.5%
2025$-1.66M+4.8%
2024$-1.74M-161.8%
2023$2.82M+751.5%
2022$-433000.00+98.5%
2021$-28.58M-2587.6%
2020$1.15M+239.1%
2019$-826000.00-103.9%
2018$21.16M+129.1%
2017$9.24M-